CONCLUSION: Sympathetic hyperactivity was associated with the composite of all-cause mortality and nonfatal cardiovascular events in CKD patients, despite treatment with ACEi or ARB. Further studies to investigate potential effects of additional sympatholytic therapy in these patients are warrented.
PMID: 19384838 [PubMed - in process] (Source: Journal of Nephrology)